Consequently, expanding treatment with TLR2 and -8 blockade to meningitis patients at the initiation of antibiotic therapy — ideally as quickly as possible upon suspected diagnosis — may be a promising therapeutic approach. This evidence concerns the gene TLR2 and infectious meningitis.